Strategic Acquisition Enclara Pharmacia was acquired by Dragonfly Health in September 2025, signaling a shift in scale, integration opportunities, and a potential consolidation around hospice and post-acute care solutions. This presents a sales opening to align with the new parent company’s roadmap and cross-sell integrated services.

Next Day Expansion Recent launch of next-day shipping infusion services in April 2025 highlights a willingness to accelerate medication access. This creates upsell opportunities for faster delivery, expanded formulary coverage, and enhanced emergency support offerings for hospices and palliative care providers.

EMR / tech Partnerships Active integrations with EMR platforms (bidirectional interface with MatrixCare in 2024 and Careficient collaboration in 2022) indicate a strong emphasis on interoperability. A sales focus can target other EMR vendors and hospice IT stakeholders to broaden integration reach and reduce workflow friction.

Nurse-Centric Platform E3 Pro and nurse-focused workflows demonstrate commitment to frontline user experience. There is an opportunity to upsell patient-care apps, nursing workflow enhancements, and clinician-facing dashboards to differentiate from competitors and improve care efficiency.

Strategic Partnerships Recent collaborations with FireNote for EMR integration and ongoing partnerships suggest a channel-driven sales approach. Target additional hospice tech platforms, care-at-home networks, and national associations to broaden partner-led distribution and co-sell opportunities.